Independent Research set a €38.00 ($44.19) price objective on Siemens Healthineers (ETR:SHL) in a research report report published on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
Several other analysts have also recently issued reports on SHL. DZ Bank reaffirmed a buy rating on shares of Siemens Healthineers in a research report on Monday, July 29th. Jefferies Financial Group set a €38.00 ($44.19) target price on Siemens Healthineers and gave the company a neutral rating in a research report on Friday, May 3rd. UBS Group set a €37.00 ($43.02) target price on Siemens Healthineers and gave the company a neutral rating in a research report on Friday, August 9th. JPMorgan Chase & Co. set a €34.90 ($40.58) price objective on Siemens Healthineers and gave the stock a neutral rating in a research report on Thursday, August 8th. Finally, Royal Bank of Canada set a €36.00 ($41.86) price objective on Siemens Healthineers and gave the stock a neutral rating in a research report on Thursday, August 8th. Fourteen investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of €38.38 ($44.62).
Shares of ETR SHL opened at €35.35 ($41.10) on Friday. The company has a current ratio of 1.30, a quick ratio of 0.87 and a debt-to-equity ratio of 55.12. The stock has a market capitalization of $35.35 billion and a PE ratio of 24.74. The stock’s fifty day simple moving average is €36.64 and its two-hundred day simple moving average is €36.60. Siemens Healthineers has a 12-month low of €31.90 ($37.09) and a 12-month high of €39.95 ($46.45).
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.